Klinische studies diffuus grootcellig B-cel lymfoom (DLBCL)

Onbehandelde patiënten

WAVELINE-011 (MK-2140-011)

A Randomized, Open-label, Multicenter, Phase 2 Study Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vdotin Plus R-CHP) in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL)

 

Behandelde patiënten

MALT1 (M23-324)

A First-in-Human Study of ABBV-525 (MALT1 Inhibitor) in B-Cell Malignancies

Vragen en contact

Laatste aanpassing: 8 januari 2026